Abdul Mannan: Two Battles, One Patient – Why Women on Anticoagulants Need Better Coordinated Care
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Too many young females on anticoagulants are fighting two battles at once:
the clot… and their periods.
Our new BloodDoctor infographic highlights a problem that still flies under the radar:
Up to 60% of patients on blood thinners experience gynaecologic bleeding.
For many, it’s not just inconvenient — it leads to iron deficiency, anaemia, and in some cases, life-threatening haemorrhagic ovarian cysts.
What struck me most while creating this resource is how often these patients end up navigating it alone, without joined-up support between haematology and gynaecology.
The evidence is clear:
1. Bleeding risk varies by drug type.
Vitamin K antagonists: 22–71%
Rivaroxaban: up to 43%
2. Multidisciplinary care changes outcomes.
The safest and most effective approach brings together:
• Haematology
• Gynaecology / Adolescent Medicine
• Primary Care
• A coordinated clinic model where decisions are shared rater than made in isolation.
When these teams work together, patients avoid the unnecessary suffering created by abrupt contraceptive changes, untreated heavy bleeding, and delayed referrals.
This is a call for better collaboration, not more complexity.
- How are your teams managing gynaecologic bleeding in patients on anticoagulants?
- What has helped improve outcomes in your service?
Let’s move the conversation forward — patients deserve nothing less.”

Find more posts featuring Abdul Mannan on Hemostasis Today.
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs